← The Wire
KLRANasdaq
Kailera Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 2096997
Develops diversified GLP-1 based obesity treatments with four clinical-stage candidates
$2.45B
Market cap
$21.67
Last close
+4.0%
1D
-5.3%
5D
582K
Volume
Price · last 39 sessions-13.6%
May 4L $18.55 · H $25.09Jun 29
6
Total filings
May 26, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 26, 20268-KResults of OperationsMay 26, 2026SC 13DSC 13DApr 23, 2026SC 13DSC 13DApr 23, 20268-KBylaw Amendment · Company UpdateApr 20, 2026424B4424B4Apr 17, 2026S-1/AS-1/AApr 13, 2026S-1S-1Mar 27, 2026
In the News
Coverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance